Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Roche Diagnostics, Cedars-Sinai; Agilent; Banyan Biomarkers, Amarantus

NEW YORK (GenomeWeb News) – Roche Diagnostics said this week that Cedars-Sinai Medical Center in Los Angeles will serve as a Roche Molecular Center of Excellence for the next five years. Cedars-Sinai offers prognostic and diagnostic tools for individualized molecular testing. One of the tests it will offer as an MCE is Roche's cobas 4800 BRAF V600 Mutation Test.

Agilent Technologies has become an industry sponsor of GreenCentre Canada, a national center of excellence for commercializing green chemistry discoveries generated by academic researchers and industry. GreenCentre Canada is funded by the governments of Ontario and Canada and focuses on developing environmentally friendly alternatives to traditional chemical and manufacturing products.

Banyan Biomarkers has signed a companion diagnostic deal with Amarantus BioSciences to evaluate a potential treatment for traumatic brain injury (TBI). Banyan has developed a biomarker-based test for TBI and said that it also intends to utilize biomarkers of neurotoxicity developed by Banyan to assess the safety of Amarantus' drug.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Filed under

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.